CYP3A5 is not a tacrolimus blood level

A report can describe CYP3A5 while a transplant team measures tacrolimus in blood. The two pieces of information are related to medicine use, but one does not tell you the value of the other. A genotype-derived label is not a substitute for a measured concentration.

The CPIC CYP3A5–tacrolimus guideline publication addresses genetic information within tacrolimus prescribing and explicitly retains therapeutic drug monitoring. It does not make a gene result an automatic record of current exposure. This article supplies no starting dose, target concentration or adjustment rule.

Name the kind of result

In a fictional example, Ren downloads a report with a CYP3A5 section and later sees a number on a blood-test portal. Ren initially stores both under “tacrolimus result”. That folder heading makes it hard to tell which is inherited information and which is a measured concentration.

Ren separates the entries. The genetic report keeps its gene assignment, interpretation, laboratory and date. The measurement keeps its test name, units, sampling date and any timing information recorded by the care team. Where timing is unknown, it is marked unknown. No blood level is inferred from the gene report.

This is a practical distinction even when the clinical team already understands both documents. It helps the person bring the right information to an appointment and avoids a misleading summary being passed to another service. A recognisable medicine name is not enough to identify the type of evidence.

Sampling context is part of the record

The NHS Specialist Pharmacy Service’s tacrolimus monitoring page discusses whole-blood trough measurements and an individualised monitoring approach. Its professional context matters. A reader should not invent sampling instructions from a generic article or assume that every result can be compared regardless of when the sample was taken.

If a care team gives instructions about the appointment and medicine timing, retain those instructions as written. If they are unclear, contact the service before the appointment. This article does not provide a universal timing interval or a reason to omit a dose. The useful action is to resolve the instruction with the team responsible for the test.

A fictional worksheet can include three fields: “sample time recorded”, “medicine timing recorded” and “team interpretation”. Leaving one field blank makes missing context visible. Filling it with an assumed routine can make a result appear more comparable than it is.

A medicine leaflet has a population too

King’s College Hospital’s tacrolimus leaflet for prevention of rejection after a liver transplant explains monitoring in that named setting. Its scope should stay attached when sharing it. A leaflet for one transplant context is not automatically the full plan for every person using the medicine.

That same care applies to a pharmacogenomic report. A section may discuss a specific use, formulation or evidence base. Before treating it as a current instruction, ask whether it fits the person’s actual treatment setting. A gene name alone cannot establish that fit.

Professional assessment may draw on several kinds of information. The reader’s task is to preserve those kinds separately so an old report does not obscure a newer measurement or a current instruction. No single coloured category should become the entire record of how a medicine is being monitored.

Keep the sequence without claiming the cause

Ren’s fictional timeline shows a genetic report, several measurement dates and a consultation note. It can help the team locate the relevant documents. It does not prove that a genotype caused a particular change between measurements. The measured values and the clinician’s explanation should remain visible rather than being replaced by a genetic story.

For a focused appointment question, try: “How does this CYP3A5 report fit alongside my current tacrolimus monitoring, and is the sampling context recorded?” Bring the full report and the team’s instructions. Ask who will record the explanation if several services are involved.

The practical takeaway is to label each item by evidence type. Genetic assignment, measured concentration and treatment instruction are three different entries. That simple organisation makes the paperwork more usable without inviting a person to estimate a blood level, skip monitoring or adjust treatment from a general article.

Scope and source access

Research accessed 4 October 2026: the CPIC publication’s indexed text, the accessible SPS monitoring page and the hospital leaflet’s indexed text. The leaflet concerns liver-transplant care; no universal sampling or prescribing instruction is inferred. Physical samples, personal records and individual treatment decisions were not assessed.